How to buy Inotiv stock (NOTV)

Inotiv is a diagnostics & research business based in the US. Inotiv shares (NOTV) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.08 – a decrease of 31.43% over the previous week. Inotiv employs 1,955 staff and has a trailing 12-month revenue of around $501.1 million.

Our top picks for where to buy Inotiv stock

Buy Inotiv stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Inotiv stock price (NASDAQ: NOTV)

Use our graph to track the performance of NOTV stocks over time.

Inotiv shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$4.08
52-week range	$1.23 - $11.42
50-day moving average more info button	$2.90
200-day moving average more info button	$3.30
Wall St. target price	$6.67
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-4.19

Is it a good time to buy Inotiv stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Inotiv price performance over time

Historical closes compared with the close of $3.84 from 2024-12-19

1 week (2024-12-13)	-35.46%
1 month (2024-11-21)	12.61%
3 months (2024-09-20)	123.91%
6 months (2024-06-21)	113.33%

1 year (2023-12-21)	7.87%
2 years (2022-12-21)	-0.78%
3 years (2021-12-21)	42.52
5 years (2019-12-20)	4.17

Is Inotiv stock undervalued or overvalued?

Valuing Inotiv stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Inotiv's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Inotiv's EBITDA

Inotiv's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $19 million.

The EBITDA is a measure of a Inotiv's overall financial performance and is widely used to measure a its profitability.

Inotiv financials

Revenue TTM	$501.1 million
Gross profit TTM	$157.2 million
Return on assets TTM	-2.92%
Return on equity TTM	-43.15%
Profit margin	-19.8%
Book value	$7.00
Market Capitalization more info button	$102.8 million

TTM: trailing 12 months

Inotiv share dividends

We're not expecting Inotiv to pay a dividend over the next 12 months.

Inotiv share price volatility

Over the last 12 months, Inotiv's shares have ranged in value from as little as $1.227 up to $11.4166. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Inotiv's is 3.374. This would suggest that Inotiv's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Inotiv overview

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company offers research and discovery services, including computational toxicology, disease pharmacology, DMPK, safety pharmacology, discovery bioanalysis, exploratory, surgical models and medical device, and cell and molecular biology; non-clinical safety assessment includes general and genetic toxicology, regulated bioanalysis, carcinogenicity studies, and development and reproductive toxicology; pathology services, such as histology, digital, clinical, and medical device pathology; bioanalysis includes nonregulated discovery bioanalysis, biotherapeutics, and regulated preclinical and clinical bioanalysis; proteomics; and consulting services, as well as model and research services. The company operates in the United States, the Netherlands, and internationally.

Frequently asked questions

null
What percentage of Inotiv is owned by insiders or institutions?
Currently 13.479% of Inotiv shares are held by insiders and 13.925% by institutions. How many people work for Inotiv?
Latest data suggests 1,955 work at Inotiv. When does the fiscal year end for Inotiv?
Inotiv's fiscal year ends in September. Where is Inotiv based?
Inotiv's address is: 2701 Kent Avenue, West Lafayette, IN, United States, 47906 What is Inotiv's ISIN number?
Inotiv's international securities identification number is: US45783Q1004